1. Home
  2. POLA vs CDT Comparison

POLA vs CDT Comparison

Compare POLA & CDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • POLA
  • CDT
  • Stock Information
  • Founded
  • POLA 1979
  • CDT 2019
  • Country
  • POLA United States
  • CDT United States
  • Employees
  • POLA N/A
  • CDT N/A
  • Industry
  • POLA Industrial Machinery/Components
  • CDT Biotechnology: Pharmaceutical Preparations
  • Sector
  • POLA Miscellaneous
  • CDT Health Care
  • Exchange
  • POLA Nasdaq
  • CDT Nasdaq
  • Market Cap
  • POLA 5.6M
  • CDT 5.2M
  • IPO Year
  • POLA 2016
  • CDT N/A
  • Fundamental
  • Price
  • POLA $2.10
  • CDT $0.54
  • Analyst Decision
  • POLA
  • CDT
  • Analyst Count
  • POLA 0
  • CDT 0
  • Target Price
  • POLA N/A
  • CDT N/A
  • AVG Volume (30 Days)
  • POLA 15.9K
  • CDT 7.4M
  • Earning Date
  • POLA 05-14-2025
  • CDT 05-13-2025
  • Dividend Yield
  • POLA N/A
  • CDT N/A
  • EPS Growth
  • POLA N/A
  • CDT N/A
  • EPS
  • POLA N/A
  • CDT N/A
  • Revenue
  • POLA $13,970,000.00
  • CDT N/A
  • Revenue This Year
  • POLA N/A
  • CDT N/A
  • Revenue Next Year
  • POLA N/A
  • CDT N/A
  • P/E Ratio
  • POLA N/A
  • CDT N/A
  • Revenue Growth
  • POLA N/A
  • CDT N/A
  • 52 Week Low
  • POLA $1.78
  • CDT $0.51
  • 52 Week High
  • POLA $4.90
  • CDT $350.00
  • Technical
  • Relative Strength Index (RSI)
  • POLA 40.75
  • CDT 36.40
  • Support Level
  • POLA $2.02
  • CDT $0.52
  • Resistance Level
  • POLA $2.27
  • CDT $1.01
  • Average True Range (ATR)
  • POLA 0.15
  • CDT 0.16
  • MACD
  • POLA 0.02
  • CDT 0.02
  • Stochastic Oscillator
  • POLA 54.33
  • CDT 3.43

About POLA Polar Power Inc.

Polar Power Inc is engaged in designing, manufacturing, and selling DC power generators, renewable energy, and cooling systems for applications in the telecommunications market and, to a lesser extent, in other markets, including military, electric vehicle, marine, and industrial. The company's products include DC generators, backup DC generators, hybrid power systems, Li-Ion battery systems, Marine DC generators, and others. The company's geographical presence is in the United States, Canada, Australia and South Pacific Islands, Asia, Europe and Middle East, United Kingdom, Other North America, South Africa, and others.

About CDT Conduit Pharmaceuticals Inc.

Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being, prioritized by biopharmaceutical companies to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready for autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor, and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.

Share on Social Networks: